1. Home
  2. HTBK vs GOSS Comparison

HTBK vs GOSS Comparison

Compare HTBK & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HTBK
  • GOSS
  • Stock Information
  • Founded
  • HTBK 1997
  • GOSS 2015
  • Country
  • HTBK United States
  • GOSS United States
  • Employees
  • HTBK N/A
  • GOSS N/A
  • Industry
  • HTBK Major Banks
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • HTBK Finance
  • GOSS Health Care
  • Exchange
  • HTBK Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • HTBK 620.0M
  • GOSS 586.6M
  • IPO Year
  • HTBK 1998
  • GOSS 2019
  • Fundamental
  • Price
  • HTBK $10.16
  • GOSS $3.46
  • Analyst Decision
  • HTBK Buy
  • GOSS Strong Buy
  • Analyst Count
  • HTBK 2
  • GOSS 6
  • Target Price
  • HTBK $11.00
  • GOSS $8.60
  • AVG Volume (30 Days)
  • HTBK 404.7K
  • GOSS 4.3M
  • Earning Date
  • HTBK 10-23-2025
  • GOSS 11-06-2025
  • Dividend Yield
  • HTBK 5.12%
  • GOSS N/A
  • EPS Growth
  • HTBK N/A
  • GOSS N/A
  • EPS
  • HTBK 0.63
  • GOSS N/A
  • Revenue
  • HTBK $180,089,000.00
  • GOSS $40,237,000.00
  • Revenue This Year
  • HTBK $10.40
  • GOSS N/A
  • Revenue Next Year
  • HTBK $7.12
  • GOSS $30.65
  • P/E Ratio
  • HTBK $16.13
  • GOSS N/A
  • Revenue Growth
  • HTBK 3.15
  • GOSS N/A
  • 52 Week Low
  • HTBK $8.09
  • GOSS $0.66
  • 52 Week High
  • HTBK $11.27
  • GOSS $3.60
  • Technical
  • Relative Strength Index (RSI)
  • HTBK 52.73
  • GOSS 76.97
  • Support Level
  • HTBK $10.12
  • GOSS $2.61
  • Resistance Level
  • HTBK $10.33
  • GOSS $3.00
  • Average True Range (ATR)
  • HTBK 0.17
  • GOSS 0.26
  • MACD
  • HTBK -0.01
  • GOSS 0.09
  • Stochastic Oscillator
  • HTBK 25.00
  • GOSS 89.47

About HTBK Heritage Commerce Corp

Heritage Commerce Corp operates as a bank holding company. The company, through its subsidiary, offers commercial banking services to small and medium-sized businesses and their owners, managers, and employees. It operates through two reportable segments, namely Banking and Factoring. A majority of its revenue is generated from the Banking segment, which provides various loan products, including commercial and industrial loans, commercial real estate loans, construction loans, etc. This segment also focuses on deposit generation on relationship accounts, encompassing non-interest bearing demand, interest bearing demand, money market accounts, certificates of deposit, and savings accounts.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: